We are live on ! Find out more
NV

Northpond Ventures Portfolio holdings

AUM $43.7M
1-Year Est. Return 27.27%
This Fund
S&P 500
This Quarter Est. Return
+15.7%
1 Year Est. Return
-27.27%
3 Year Est. Return
-67.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$175M
AUM Growth
-$9.37M
Cap. Flow
-$3.8M
Cap. Flow %
-2.17%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
CELL
PhenomeX Inc. Common Stock
CELL
+$9.85M

Top Sells

Rank Stock Value
1
ISO
IsoPlexis Corporation Common Stock
ISO
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DICE
1
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$94.3M 53.91%
3,292,871
– –
VIGL
2
DELISTED
Vigil Neuroscience
VIGL
$41.3M 23.58%
4,214,498
– –
TBIO
3
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$30.5M 17.44%
546,896
– –
CELL
4
DELISTED
PhenomeX Inc. Common Stock
CELL
$6.25M 3.57%
+5,390,820
New +$9.85M
CADL icon
5
Candel Therapeutics
CADL
$689M
$2.61M 1.49%
1,935,215
– –
ISO
6
DELISTED
IsoPlexis Corporation Common Stock
ISO
– –
-8,808,531
Closed -$13.7M

Similar funds

GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
SCMC
Serent Capital Management Company San Francisco, California $44.9M AUM 20.57% 1-Year Est. Return
AS
AM Squared Hong Kong $45.2M AUM 4.27% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Northpond Ventures's Q1 2023 Portfolio in Review

As of Q1 2023, Northpond Ventures held 6 positions worth $175M, down 5.1% from $184M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Northpond Ventures's Q1 2023 filing shows 1 new and 1 closed positions. Its largest new stake was PhenomeX Inc. Common Stock: 5,390,820 shares worth $6.25M. The largest sale was IsoPlexis Corporation Common Stock, an estimated $13.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Northpond Ventures's largest Q1 2023 buy was PhenomeX Inc. Common Stock: 5,390,820 shares worth $6.25M.
  • Northpond Ventures fully exited IsoPlexis Corporation Common Stock in Q1 2023, selling an estimated $13.7M.
  • Northpond Ventures's ten largest holdings make up 100% of its $175M portfolio in Q1 2023.
  • Northpond Ventures opened 1 new position and closed 1 in Q1 2023.
  • Northpond Ventures's portfolio value fell 5.1% quarter-over-quarter to $175M.

Based on Northpond Ventures's 13F filing for Q1 2023, filed 15 May 2023.